Nano-Proprietary Announces the Principles of Remote Detection of Explosives - New Technology

Nano-Proprietary, Inc. through its subsidiary, Applied Nanotech, Inc. (ANI), today announced that during its participation at the Defense Research and Engineering Conference and Exposition sponsored by The American Society of Mechanical Engineers International that took place in Washington, D.C., November 17-19, 2003, it presented for the first time the concept of remote detection of explosives using nanodetectors. The use of nanoscale sensors for CBRE (chemical, biological, radiological and explosive agents) could critically impact national security programs by providing sensitive, selective and inexpensive sensors that can be deployed for advanced security for transportation, military, border crossing, civilian business, federal buildings, etc.

At this conference, Applied Nanotech, Inc.'s CEO, Dr. Zvi Yaniv, during his invited talk entitled "Current Applications of Nanotechnology and Future Outlook For Security Systems", presented a new concept for remote detection of explosives. Airborne nanodetectors can be strategically placed to detect the presence of explosives. These nanodetectors, such as selective quantum dots, nanoporous silicon particles, bioluminescent molecules, etc., which are totally harmless to the environment and living organisms, change their optical characteristics in the presence of chemicals embedded in explosives. These changes can be easily detected from a large distance, for example, using usual photomultipliers already utilized in many light detection applications. 

"This is a natural extension of our sensor patents and know-how using nanotechnology," said Dr. Zvi Yaniv, CEO of Applied Nanotech, Inc. "We are now in the process of selecting a partner to help us create a working prototype," continued Dr. Yaniv.

Posted 24th November 2003

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.